TRPC5 and neoplasm: Although Carson et al. have also shown that EA activates TRPC4 and TRPC5 to inhibit tumor cell growth5, a diterpene ester, tonantzitlolone can cause cytotoxicity in renal cancer cells via the activation of PKCθ6.